Burkholderia cepacia complex infection in cystic fibrosis patients: Mechanisms of pathogenesis

Reviews and Research in Medical Microbiology

Volumn 15, Issue 3, 2004, Pages 93-101

  Ryley, H C ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Burkholderia cepacia complex; Cystic fibrosis; Pathogenesis; Virulence

Indexed keywords

EXOTOXIN; LIPOPOLYSACCHARIDE; SIDEROPHORE; VIRULENCE FACTOR;

BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BIOFILM; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA MULTIVORANS; CELL INVASION; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VIVO STUDY; INFECTION; LUNG; MUTAGENESIS; PATHOGENICITY; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SURVIVAL; VIRULENCE;

EID: 13444263841     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-200407000-00002     Document Type: Review

References (83)

1. Ryley HC. Burkholderia cepacia complex infection in cystic fibrosis patients: 1: laboratory investigations, epidemiology and clinical management. Rev Med Microbiol 2003, 14:15-24.
2. Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp.nov. Intl J System Bacteriol 1997, 47:1188-1200.
3. Vandamme P, Holmes B, Coenye T, Goris J, Mahenthiralingam E, LiPuma JJ, Govan JRW. Burkholderia cenocepacia sp. nov - a new twist to an old story. Res Microbiol 2003, 154:91-96.
4. Vandamme P, Mahenthiralingam E, Holmes B, Coenye T, Hoste B, de Vos P, et al. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia Genomovar IV). J Clin Microbiol 2000, 38:1042-1047.
5. Vermis K, Coenye T, LiPuma JJ, Mahenthiralingam E, Nelis HJ, Vandamme P. Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Intl J System Evol Microbiol 2004, 55:589-691.
6. Coenye T, Mahenthiralingam E, Henry D, Li Puma JJ, Laevens S, Gillis, et al. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Intl J System Evol Microbiol 2001, 51:1481-1490.
7. Vandamme P, Henry D, Coenye T, Nzula S, Vancanneyt M, LiPuma JJ, et al. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol Med Microbiol 2002, 32:143-149.
8. Cystic Fibrosis Trust Infection Control Group. A statement on Burkholderia cepacia July 1999. http://www.cftrust.org.uk/scope/ documentlibrary/CFTRust/Burkholderia%20cepacia.pdf
9. Govan JRW, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993, 342:15-19.
10. Holmes A, Nolan R, Taylor R, Finley R, Riley M, Jiang R-Z, et al. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 1999, 179:1197-1205.
11. Steinbach S, Sun L, Jiang R-Z, Flume P, Gilligan P, Egan TM, et al. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med 1994, 331:981-987.
12. Ryley HC, Ojeniyi, Høiby N, Weeks J. Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1996, 15:755-758.
13. + Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nature Med 1995, 1:661-666.
14. Sajjan US, Sun L, Goldstein R, Forstner JF. Cable (Cbl) Type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: Nucleotide sequence of cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol 1995, 177:1030-1038.
15. Sajjan SU, Forstner JF. Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun 1992, 60:1434-1440.
16. Sajjan US, Sylvester FA, Forstner JF. Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun 2000, 68:1787-1795.
17. Sajjan U, Wu Y, Kent G, Forstner J. Preferential adherence of cable-piliated Burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. J Med Microbiol 2000, 49:875-885.
18. LiPuma JJ, Spilker T, Gill LH, Campbell PW, Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 2001, 164:92-96.
19. Sajjan U, Liu L, Lu A, Spilker T, Forstner J, LiPuma JJ. Lack of cable pili expression by Cab/4-containing Burkholderia cepacia complex. Microbiology 2002, 148:3477-3484.
20. Goldstein R, Sun L, Jiang RZ, Sajjan U, Forstner JF, Campanelli C. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol 1995, 177:1039-1052.
21. Mahenthiralingam E, Simpson DA, Speert DP. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 1997, 35:808-816.
22. Clode FE, Kaufmann ME, Malnick H, Pitt TL. Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol 2000, 38:1763-1766.
23. LiPuma JJ, Spilker T, Gill LH, Campbell PW, Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 2001, 164:92-96.
24. McDowell A, Mahenthiralingam E, Dunbar KEA, Moore JE, Crowe M, Elborn JS. Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation. J Med Microbiol 2004, 53: 663-668.
25. Baldwin A, Sokol PA, Parkhill J, Mahenthiralingam E. The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun 2004, 72: 1537-1547.
26. Parsons YN, Banasko R, Detsika MG, Duangsonk K, Rainbow L, Hart CA, et al. Suppression-subtractive hybridisation reveals variations in gene distribution amongst the Burkholderia cepacia complex, including the presence in some strains of a genomic island containing putative polysaccharide production genes. Arch Microbiol 2003, 179:214-223.
27. Costerton JW. Cystic fibrosis pathogenesis and the role of biofilm in persistent infection. Trends Microbiol 2001, 9:50-52.
28. Mohr CD, Tomich M, Herfst CA. Cellular aspects of Burkholderia cepacia infection. Microbes Infect 2001, 3:425-435.
29. Conway BA, Venu V, Speert DP. Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex. J Bacteriol 2002, 184:5678-5685.
30. Huber B, Riedel K, Hentzer M, Heydorn A, Gotschlich A, Givskov M, et al. The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 2001, 147:2517-2528.
31. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998, 280:295-298.
32. Lewenza S, Conway B, Greenberg EP, Sokol PA. Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI. J Bacteriol 1999, 181:748-756.
33. Gotschlich A, Huber B, Geisenberger O, Togl A, Steidle A, Riedel K, et al. Synthesis of multiple N-acylhomoserine lactones is wide-spread among the members of the Burkholderia cepacia complex. Syst Appl Microbiol 2001, 24:1-14.
34. Venturi V, Friscina A, Bertani I, Devescovi G, Aguilar C. Quorum sensing in the Burkholderia cepacia complex. Res Microbiol 2004, 155:238-244.
35. Sage A, Linker A, Evans LR, Lessie TG. Hexose phosphate-metabolism and exopolysaccharide formation in Pseudomonas-Cepacia. Curr Microbiol 1990, 20:191-198.
36. Cérantola S, Lemassu-Jacquier A, Montrozier H. Structural elucidation of a novel exopolysaccharide produced by a mucoid clinical isolate of Burkholderia cepacia. Eur J Biochem 1999, 260:373-383.
37. Linker A, Evans LR, Impallomeni G. The structure of a polysaccharide from infectious strains of Burkholderia cepacia. Carbohydr Res 2001, 335:45-54.
38. Sist P, Cescutti P, Skerlavaj S, Urbani R, Leitão JH, Sá-Correia I, Rizzo R. Macromolecular and solution properties of Cepacian: the exopolysaccharide produced by a strain of Burkholderia cepacia isolated from a cystic fibrosis patient. Carbohydr Res 2003, 338:1861-1867.
39. Richau JA, Leitão JH, Correia M, Lito L, Salgado MJ, Barreto C, et al. Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center. J Clin Microbiol 2000, 38:1651-1655.
40. Lagatolla C, Skerlavaj S, Dolzani L, Tonin EA, Bragadin CM, Bosco M, et al. Microbiological characterisation of Burkholderia cepacia isolates from cystic fibrosis patients: investigation of the exopolysaccharides produced. FEMS Microbiol Lett 2002, 209:99-106.
41. Cérantola S, Montrozier H. Production in vitro, on different solid culture media, of two distinct exopolysaccharides by a mucoid clinical strain of Burkholderia cepacia. FEMS Microbiol Lett 2001, 202:129-133.
42. Moreira LM, Videira PA, Sousa SA, Leitão JH, Cunha MV, Sá-Correia I. Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide. Biochem Biophys Res Comm 2003, 312:323-333.
43. Cunha MV, Sousa SA, Leitão JH, Moreira LM, Videira PA, Sá-Correia I. Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J Clin Microbiol 2004, 42:3052-3058.
44. Stapper PA, Narasimhan G, Ohman DE, Barakat J, Hentzer M, Molin S, et al. Alginate production affects Pseudomonas aeruginosa biofilm development and architecture, but is not essential for biofilm formation. J Med Microbiol 2004, 53:679-690.
45. Schwab U Leigh M, Ribeiro C, Yankaskas J, Burns K, Gilligan P, et al. Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airways epithelia. Infect Immun 2002, 70:4547-4555.
46. Burns JL, Jonas M, Chi EY, Clark DK, Berger A, Griffith A. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun 1996, 64:4054-4059.
47. Tipper JL, Ingham E, Cove JH, Todd NJ, Kerr KG. Survival and multiplication of Burkholderia cepacia within respiratory epithelial cells. Clin Microbiol Infect 1998, 4:450-459.
48. Martin DW, Mohr CD. Invasion and intracellular survival of Burkholderia cepacia. Infect Immun 2000, 68:24-29.
49. Schwab UE, Ribeiro CMP, Neubauer H, Boucher RC. Role of actin filament network in Burkholderia multivorans invasion in well-differentiated human airway epithelia. Infect Immun 2003, 71:6607-6609.
50. Sajjan U, Keshavjee S, Forstner J. Responses of well-differentiated airway epithelial cell cultures from healthy donors and patients with cystic fibrosis to Burkholderia cenocepacia infection. Infect Immun 2004, 72:4188-4199.
51. Sajjan U, Corey M, Humar A, Tullis E, Cutz E, Ackerley C, Forstner J. Immunolocalisation of Burkholderia cepacia in the lung of cystic fibrosis patients. J Med Microbiol 2001, 50: 535-546.
52. Sokol PA. Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia. J Clin Microbiol 1986, 23:560-562.
53. Meyer JM, Hohnadel D, Halle F. Cepabactin from Pseudomonascepacia, a new type of siderophore. J Gen Microbiol 1989, 135:1479-1487.
54. Darling P, Chan M, Cox AD, Sokol PA. Siderophore production by cystic fibrosis isolates of Burkholderia cepacia. Infect Immun 1998, 66:874-877.
55. 5-oxygenase. Infect Immun 1999, 67: 4443-4455.
56. Sokol PA, Darling P, Lewenza S, Corbett CR, Kooi CD. Identification of a Siderophore receptor required for ferric ornibactin uptake in Burkholderia cepacia. Infect Immun 2000, 68:6554-6560.
57. Visser MB, Majumdar S, Hani E, Sokol PA. Importance of the ornibactin and pyochelin siderophore transport systems in Burkholderia cenocepacia lung infections. Infect Immun 2004, 72:2850-2857.
58. Cash HA, Woods DE, McCullough B, Johanson WC, Bass JA. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis 1979, 119:453-459.
59. Govan JRW, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996, 60:539-574.
60. Straus DC, Lonon MK, Hutson JC. Inhibition of rat alveolar macrophage function by Pseudomonas cepacia lipase. J Med Microbiol 1992, 37:335-340.
61. Hutchison ML, Poxton IR, Govam JRW. Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian Phagoctes. Infect Immun 1998, 66:2033-2039.
62. Punj V, Sharma R, Zaborina O, Chakrabarty AM. Energy-generating enzymes of Burkholderia cepacia and their interactions with macrophages. J Bacteriol 2003, 185:3167-3178.
63. Tomich M, Griffith A, Herfst CA, Burns JL, Mohr CD. Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun 2003, 71: 1405-1415.
64. Glendinning KJ, Parsons YN, Duangsonk K, Hales A, Humphreys D, Hart CA, et al. Sequence divergence in type III secretion gene clusters of the Burkholderia cepacia complex. FEMS Microbiol Lett 2004, 235:229-235.
65. Smith H. What happens to bacterial pathogens in vivo. Trends Microbiol 1998, 6:239-243.
66. Hunt TA, Kooi C, Sokol PA, Valvano MA. Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 2004, 72:4010-4022.
67. Morrison GM, Davidson DJ, Kilanowski FM, Borthwich DW, Crook K, Maxwell AI, et al. Mouse beta defensin 1 is a functional homolog of human beta defensin 1. Mamm Genome 1998, 9:453-457.
68. Saiman L, Tabibi S, Starner TD, San Gabriel P, Winokur PL, Jia HP, et al. Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother 2001, 45:2838-2844.
69. Sahly H, Schubert S, Harder J, Rautenberg P, Ullmann U, Schröder J, et al. Burkholderia Is highly resistant to human beta-defensin 3. Antimicrob Agents Chemother 2003, 47:1739-1741.
70. Cox AD, Wilkinson SG. Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance. Mol Microbiol 1991, 5:641-646.
71. Albrecht MT, Wang W, Shamova O, Lehrer RI , Schiller NL. Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia. Respir Res 2002, 3:18-28.
72. Zughairer SM, Ryley HC, Jackson SK. A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates the monocyte respiratory burst activity by scavenging superoxide anions. Infect Immun 1999, 67:908-913.
73. Shaw D, Poxton IR, Govan JRW. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol Med Microbiol 1995, 11:99-106.
74. Zughaier SM, Ryley HC, Jackson SK. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect Immun 1999, 67:1505-1507.
75. De Soyza A, Ellis CD, Anjam Khan CM, Corris PA, Demarco de Hormaeche R. Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am J Respir Crit Care Med 2004, 170:70-77.
76. Reddi K, Phagoo SB, Anderson KD, Warburton D. Burkholderia cepacia-induced IL-8 gene expression in an alveolar epithelial cell line: signaling through CD14 and mitogen-activated protein kinase. Pediatr Res 2003, 54:297-305.
77. Hughes JE, Stewart J, Barclay GR, Govan JRW. Priming of neutrophils respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun 1997, 65:4281-4287.
78. Biddick R, Spilker T, Martin A, LiPuma JJ. Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. FEMS Microbiol Lett 2003, 228:57-62.
79. Scott FW, Pitt TL. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 2004, 53:609-615.
80. Armstrong DS, Nixon GM, Carzino R, Bigham A, Carlin JB, Robins-Browne RM, et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002, 166:983-987.
81. Mall M, Grubb BR, Harkema JR, O'Neal WK, Boucher RC. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nature Med 2004, 10:487-493.
82. Parsons YN, Panagea S, Smart CHM, Walshaw MJ, Hart CA, Winstanley C. Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. J Clin Microbiol 2002, 40:4607-4611.
83. Miller DA, Jones AM, Webb AK, Govan JRW, Speert DP, Smith C, Mahenthiralingam E. Identification and prevalence of DNA markers specific to a multiresistant and transmissible clone of Pseudomonas aeruginosa. J Cystic Fibrosis 2004, 3(Suppl 1):S38.